ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2691

Clinical, Radiological and Functional Characteristics of Clinically Significant Pulmonary Involvement in Primary SjöGren’s Syndrome

Christos F Kampolis1, Sofia Fragkioudaki1, Alexandra Zormpala2, Anastasia Samakovli3 and Haralampos M. Moutsopoulos1, 1Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, 2Radiology, "Laiko" General Hospital, Athens, Greece, 3Respiratory Department, “Evgenidion Clinic Agia Trias”, Athens, Greece

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Lung Disease and Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Sjögren's Syndrome - Poster II: Clinical Science

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Prevalence of symptomatic pulmonary disease in primary Sjögren’s Syndrome (pSS) ranges between 9% and 27%. Xerotrachea, small airway disease and interstitial lung disease (ILD) are among the most common manifestations. However, the evidence is conflicting on which of the above mentioned respiratory disorders is the most prevalent in pSS patients. The purpose of the present study is to estimate the prevalence and type of chronic respiratory symptoms in a large cohort of pSS and associate them with disease-specific clinical and laboratory parameters.

Methods:  Consecutive patients with pSS were questioned for chronic respiratory symptoms (cough, dyspnea or both). Patients with pre-existing respiratory symptoms before the onset of pSS were excluded from further investigation. The remaining symptomatic patients were assessed clinically, with PFTs (pre- and post-bronchodilator spirometry, static lung volumes and diffusion capacity) and high resolution CT (hrCT) on inspiratory and expiratory phase. Clinical and laboratory characteristics taken from the patient’s records were compared between symptomatic and asymptomatic patients and between patients with ILD and other non ILD respiratory disorder related to pSS.

Results: Thus far, 348 patients have been screened from an initial cohort of 723 pSS patients. According to preliminary analysis, chronic respiratory symptoms were detected in 24% (84/348) of patients. Two thirds of the cases (55/84) were attributed to pSS. PFTs and chest hrCT were performed in 34 patients. Eighteen patients (18/34 or 53%) were diagnosed with small airway disease, while only 5 patients (15%) had ILD. Xerotrachea was considered responsible for chronic cough, in symptomatic patients with normal PFTs and normal or non-specific CT findings (11/34 or 32%). There were no statistically significant differences in clinical and laboratory parameters between symptomatic and asymptomatic patients, patients with ILD, patients with small airway disease or symptoms related to xerotrachea.

Conclusion:  Small airway disease is the most common pulmonary manifestation in patients with chronic respiratory symptoms and pSS, while ILD is less frequent than previously thought.


Disclosure: C. F. Kampolis, None; S. Fragkioudaki, None; A. Zormpala, None; A. Samakovli, None; H. M. Moutsopoulos, None.

To cite this abstract in AMA style:

Kampolis CF, Fragkioudaki S, Zormpala A, Samakovli A, Moutsopoulos HM. Clinical, Radiological and Functional Characteristics of Clinically Significant Pulmonary Involvement in Primary SjöGren’s Syndrome [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/clinical-radiological-and-functional-characteristics-of-clinically-significant-pulmonary-involvement-in-primary-sjogrens-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-radiological-and-functional-characteristics-of-clinically-significant-pulmonary-involvement-in-primary-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology